| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |